Genmab — April 2019
-
a bit of biotech history "The entrepreneur behind the cancer immunotherapy revolution" https://news.yahoo.com/entrepreneur-behind-cancer-immunotherapy-revolution-083047116.html
-
article in Cancer earlier this month "Daratumumab in multiple myeloma" https://onlinelibrary.wiley.com/doi/abs/10.1002/cncr.32065
-
now in full available via https://sci-hub.tw/https://doi.org/10.1002/cncr.32065
-
-
@Sukkeralf do you still expect anything from the CD123xCD3 ? i noticed last week another 2 hospitals are 'withdrawn' in that clinical trial...
-
-
Ja også mig. Det må være den shutdown der giver forsinkelsen. Hvornår længe varede
den nu? En måned ikk’? -
Har lige skrevet en større analyse om tålmodig investering ind i de lange megatrends. Her har jeg Genmab med: "Med lægemidlet Darzalex mod knoglemarvskræft rammer Genmab-casen ind i en global sundhedstendens, hvor mennesker lever længere. Knoglemarvskræft opstår hyppigere med alderen og der forventes en stor stigning i antallet mennesker med den alvorlige sygdom i de næste mange år".
-
Og ja Vitus...Jeg er meget tålmodig som altid.
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind